Keratoconus is a progressive, asymmetric condition characterized by corneal thinning and cone-shaped corneal protrusion, leading to a decline of the visual acuity. The therapeutic choice depends on the severity of the pathology. In moderate or severe cases, corneal cross-linking or intrastromal corneal ring segment implantation (ICRS) is commonly used. However, these fail in the predictable recovery of corneal curvature. A new approach that aims to address the current limitations of keratoconus treatments has been developed by the medtech company Recornea and involves implanting the Grosso® Reshaper device inside the affected cornea. This Nitinol-based device is designed to restore the physiological curvature of the cornea and enhance the patient's quality of vision.